PharmaBoardroom

Interview PH Huang – Chairman & CEO, JCP Works, Taiwan

JCP is home to over five decades of generic medication production and is a cornerstone household brand for numerous products in Taiwan’s domestic…

Parallel Trade in Polish Pharma: The Good and the Bad

Poland’s entrance into the EU has been a catalyst for growth that has allowed the country to flourish, shown by the nation’s ranking as the…

Interview: Fangchen Lee – Chairman, YungShin Global…

Fangchen Lee, Chairman of YungShin Global Holding on strengthening the groups's vertical integration, expanding product portfolio, and instilling…

Interview: Dr. Joel Osorio – Co-Founder & CEO,…

[caption id="attachment_58935" align="alignleft" width="150"] Joel Osorio, CEO & Founder[/caption] [caption id="attachment_59290"…

Matti Arvela – General Manager, Amgen Greece

Amgen’s mission is clear cut: ‘To Serve Patients’, which is evident in the level of innovation that they bring as the world’s leading biotech…

Europe Facts & Figures Snapshot

Europe accounts for 22.2 percent of global pharma sales; more than Africa, Asia, Australasia, and Latin America combined, but less than half of North…

Interview: MS Nagendra – Director General, Zydus…

M.S. Nagendra, Director General at Zydus Pharmaceuticals Mexico, explains the company’s unique business model, combining both branded generics and…

Interview: Paulo de Resende – CEO, Laboratorios Grin-Lupin,…

Paulo de Resende, CEO of Laboratorios Grin-Lupin in Mexico, describes the current state of the Mexican pharmaceutical market and explains how the…

Eugenia Nicolaou – CEO, Anfarm, Greece

Carrying the legacy of an accomplished Greek family business, Anfarm CEO Eugenia Nicolaou speaks proudly about the company’s evolution, how Anfarm…

Interview: Thierry Volle – President EMEA, Lupin

Lupin’s EMEA President Thierry Volle explains that to fuel growth in the EMEA region, Lupin is investing heavily in transforming the business from a…

Interview: Yita Lee Ph.D – Deputy Chairman, Sinphar Group;…

Yita Lee & Muh-Hwan Su of Sinphar Group & SynCore Bio describe the exciting R&D projects of SynCore Bio, the oncology & dry AMD…

Interview: Piero Poli – President & CEO, Rivopharm,…

Niche generics manufacturer Rivopharm was nearly bankrupt when acquired by current president and CEO Piero Poli in 2005; he explains the changes and…

Tagged with GEN